SYNDAX PHARMACEUTICALS INC's ticker is and the CUSIP is 87164F905. A total of 2 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,888 | +8651.5% | 198,900 | +12331.2% | 0.00% | – |
| Q2 2023 | $33 | +230.0% | 1,600 | +220.0% | 0.00% | – |
| Q1 2023 | $10 | -16.7% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $12 | -100.0% | 500 | -85.3% | 0.00% | – |
| Q3 2022 | $81,000 | +52.8% | 3,400 | +21.4% | 0.00% | – |
| Q2 2022 | $53,000 | +430.0% | 2,800 | +366.7% | 0.00% | – |
| Q1 2022 | $10,000 | +400.0% | 600 | +500.0% | 0.00% | – |
| Q4 2021 | $2,000 | -96.8% | 100 | -97.1% | 0.00% | – |
| Q3 2021 | $62,000 | +3.3% | 3,500 | 0.0% | 0.00% | – |
| Q2 2021 | $60,000 | -63.2% | 3,500 | +4694.5% | 0.00% | – |
| Q1 2021 | $163,000 | +1937.5% | 73 | +1725.0% | 0.00% | – |
| Q4 2020 | $8,000 | +300.0% | 4 | +100.0% | 0.00% | – |
| Q3 2020 | $2,000 | -97.4% | 2 | -96.2% | 0.00% | – |
| Q2 2020 | $78,000 | -73.6% | 53 | -80.4% | 0.00% | -100.0% |
| Q1 2020 | $296,000 | +116.1% | 270 | +72.0% | 0.00% | – |
| Q4 2019 | $137,000 | +42.7% | 157 | +21.7% | 0.00% | – |
| Q3 2019 | $96,000 | +140.0% | 129 | +193.2% | 0.00% | – |
| Q2 2019 | $40,000 | +900.0% | 44 | +388.9% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 9 | +50.0% | 0.00% | – |
| Q4 2018 | $2,000 | -98.3% | 6 | -95.9% | 0.00% | – |
| Q3 2018 | $119,000 | +56.6% | 148 | +42.3% | 0.00% | -100.0% |
| Q1 2018 | $76,000 | – | 104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $2,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,800 | $53,000 | 0.00% |
| JANE STREET GROUP, LLC | 15,400 | $296,000 | 0.00% |